Author: Claude (AI), from PubMed abstracts · Reviewed by: Dr Mina Abdelmseih · Reviewed: 2026-11-15 · Review due: 2027-11-15

Educational content only. Not personalised medical advice. Clinical decisions remain the responsibility of the treating clinician.

Low-vision rehabilitation

Low-vision rehabilitation aims to optimise the use of residual vision after severe, permanent vision loss, teach skills for daily life, and help people adapt and stay socially engaged [S7]. Rehabilitation services improve clinical and functional ability, but effects on quality of life are small or uncertain [S1] [S7]. Evidence from low- and middle-income countries is scarce, although optical devices appear to help in sub-Saharan Africa [S8] [S11].

Key points - A Cochrane review of 44 RCTs found no evidence of benefit on health-related quality of life, but a small benefit on vision-related quality of life from methods of enhancing vision (moderate certainty) [S7]. - Stand-mounted electronic magnifiers (CCTV) may give faster reading than optical magnifiers (low certainty); there is no good evidence for filters or prism spectacles [S5]. - Depression is common and treatable: integrating behaviour activation with rehabilitation halved new depressive disorders in AMD (12.6% vs 23.4%) [S2]. - Gains can fade: in VA LOVIT II, visual reading ability declined between 4 months and 1 year [S6]. - In sub-Saharan Africa, only three studies were found; all reported better acuity and reading with optical devices [S11].

Evidence last checked: 2026-10-17 (PubMed abstracts).

Red flags

• Treatable cause not yet excluded. Cochrane trials enrolled adults with irreversible visual impairment [S7]. A person with recent or unexplained vision loss needs a diagnostic eye examination before rehabilitation [EIC expert opinion].
• Depression or withdrawal. Service providers should be trained to recognise depression and anxiety and have referral pathways to mental health services [S8].
• Further loss of near vision. Loss of near acuity predicted loss of reading ability over a year [S6].

Recognise it: who needs rehabilitation

• Mainly older adults, often with age-related macular degeneration, in high-income settings [S7] [S10].
• Children: no RCTs of optical reading aids for children met Cochrane criteria [S3]; in sub-Saharan Africa many students enrolled in schools for the blind retained functional vision [S11].
• Almost no useful outcome data exist for children and people of working age [S1].

Confirm it: assessment

• Trials measured reading speed, critical print size, near activities and vision-related quality of life [S4] [S5] [S7].
• One-year follow-up is recommended for patients with macular disease to detect functional change and modify the plan [S6].

Manage it

Before acting on this section, check the national and local guidelines, product information and regulatory approvals that apply where you practise. See the medical disclaimer.

Tier A (primary care / no specialist)

• Identify people with permanent vision loss who struggle with daily tasks and link them to rehabilitation or community services [S1].
• Visual rehabilitation that has been shown to work can be delivered by non-specialists [S8].
• Screen for low mood and refer to mental health services where available [S8].

Tier B (general eye clinic)

1. Optical devices first. Stand and hand magnifiers are the comparator in most trials [S5]; in sub-Saharan Africa, optical devices improved distance and near acuity, reading speed and errors [S11].
2. Add electronic magnifiers where affordable. Portable electronic magnifiers (p-EVES) added to optical aids allowed smaller print, longer reading and more independent tasks; 70% preferred them for leisure reading, although optical aids were used for more tasks [S4].
3. Avoid unproven aids. Coloured filters and prism spectacles are not supported [S5].
4. Review at 1 year [S6].

Tier C (specialist centre)

• Multidisciplinary rehabilitation. One low-risk-of-bias trial of intensive rehabilitation showed a very large effect on vision-related quality of life versus inactive control; a second showed a small, uncertain effect [S7]. Against active controls, no additional benefit was found [S7].
• Mental health integration. Behaviour activation with rehabilitation reduced depressive disorders (adjusted RR 0.51) [S2]; psychological or group programmes gave a small benefit on depression versus usual care (moderate certainty) [S7].
• Self-management programmes. Little or no effect on quality of life (low certainty) [S10].
• Telerehabilitation. Only one small, high-risk-of-bias trial was found; outcomes were similar to self-guided training [S9].

Refer when

Pitfalls

• Promising better quality of life: overall effects are small [S7].
• Dispensing devices without follow-up: reading benefits decline over a year [S6].
• Ignoring depression [S2] [S8].
• Paying for expensive technology without evidence of added benefit for the person [S5].

Evidence notes

• Most evidence comes from high-income countries and older adults with AMD [S7] [S10]; only four LMIC studies had low risk of bias [S8].
• Follow-up was mostly 6 months or less [S7].
• No cost-effectiveness data were reported in the 2012 review [S1].
• A 2021 meta-analysis in the search results was flagged as retracted and was excluded.
• Not covered by these sources: orientation and mobility training outcomes, braille, and specific magnifier prescribing methods.

Related articles

• Geographic Atrophy: Beyond Complement Inhibition
• Cerebral visual impairment in children

References

See the numbered source list below. Each marker [S#] links to its PubMed and DOI record.